Company News Summary | 29 Jul 2021
Click the print icon in your browser to print this report. Currency is in AUD unless otherwise specified
Australian Pharmaceutical Industries Announces Board Rejects Indicative Proposal from Wesfarmers
09:11:00 | Associate analysts
Original annuncemenet:API Board rejects indicative proposal from Wesfarmers
Australian Pharmaceutical Industries announced that it had received an unsolicited, non-binding, conditional indicative proposal (the Indicative Proposal) from Wesfarmers to acquire 100% of the shares in the Company by way of a scheme of arrangement for cash consideration of $1.38 per share. The Company Board (the Board) has carefully considered the Indicative Proposal, including obtaining advice from its financial and legal advisers. The Board has unanimously concluded that the Indicative Proposal undervalues the Company, is not compelling and is not in the best interests of its shareholders.
|This report appeared on www.morningstar.com.au||2021 Morningstar Australasia Pty Limited|
© Copyright 2021 Morningstar Australasia Pty Ltd ABN: 95 090 665 544 ("Morningstar"), AFSL no 240892. (a subsidiary of Morningstar, Inc.). This information is to be used for personal, non-commercial purposes only. No reproduction is permitted without the prior written content of Morningstar. Some of the material provided is published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO").